-+ 0.00%
-+ 0.00%
-+ 0.00%
UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million
Share
Listen to the news
UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million
  • UroGen Pharma Chief Medical Officer Mark Schoenberg sold 60,677 ordinary shares on Aug. 20, 2026.
  • Sale priced at USD 47.05 per share on a weighted-average basis.
  • Post-transaction holding totaled 59,086 ordinary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Urogen Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028840), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending